Astex Pharmaceuticals to Present at JMP Securities Healthcare Conference
DUBLIN, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, and Mohammad Azab, MD, chief medical officer, will present at the 8th Annual JMP Securities Healthcare Conference on Wednesday July 10th in New York City.
The Company's presentation will begin at 2:00 p.m. ET. A live webcast of the presentation will be available in the Investor Events section of the Company's website, www.astx.com . The webcast will be archived for 30 days.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com .
CONTACT: Timothy L. Enns Astex Pharmaceuticals, Inc. Senior Vice President Corporate Communications & Marketing Tel: +1 (925) 560-2810 E-mail: email@example.com Susanna Chau Astex Pharmaceuticals, Inc. Manager Investor Relations Tel: +1 (925) 560-2845 E-mail: firstname.lastname@example.org Alan Roemer The Trout Group Managing Director Tel: +1 (646) 378-2945 E-mail: email@example.com
Source: Astex Pharmaceuticals, Inc. 2013 GlobeNewswire, Inc.